December 1, 2021
Research from the University of Cincinnati College of Medicine shows that use of a topical drug, called AB569, a combination of acidified nitrite and EDTA (or ethylenediaminetetraacetic acid) promotes killing of antibiotic-resistant bacteria while enhancing the healing of wounds in a variety of burn injuries. The study was published in the journal Infection and Immunity.
November 30, 2021
New research on the forcible separation of families at the U.S.-Mexico border, shows that many parents and children showed long-term, serious mental health disorders such as post-traumatic stress disorder (PTSD), anxiety and depression. In a story on the study, the Dallas Morning News interviewed several expert sources, including Maria Espinola, PsyD, assistant professor in the Department of Psychiatry and Behavioral Neuroscience at the UC College of Medicine.
November 29, 2021
Over the Thanksgiving weekend, the World Health Organization gave the name omicron to the newest identified version of SARS-CoV-2 and called it a variant of concern. There is still much to be learned about this latest variant and how potentially dangerous it is. In a story on the variant, Cincinnati.com interview Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
December 1, 2021
Research from the University of Cincinnati College of Medicine shows that use of a topical drug, called AB569, a combination of acidified nitrite and EDTA (or ethylenediaminetetraacetic acid) promotes killing of antibiotic-resistant bacteria while enhancing the healing of wounds in a variety of burn injuries. The study was published in the journal Infection and Immunity.
November 30, 2021
New research on the forcible separation of families at the U.S.-Mexico border, shows that many parents and children showed long-term, serious mental health disorders such as post-traumatic stress disorder (PTSD), anxiety and depression. In a story on the study, the Dallas Morning News interviewed several expert sources, including Maria Espinola, PsyD, assistant professor in the Department of Psychiatry and Behavioral Neuroscience at the UC College of Medicine.
November 29, 2021
Over the Thanksgiving weekend, the World Health Organization gave the name omicron to the newest identified version of SARS-CoV-2 and called it a variant of concern. There is still much to be learned about this latest variant and how potentially dangerous it is. In a story on the variant, Cincinnati.com interview Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
November 19, 2021
In a story for Reuters Health published by Medscape, it was reported that Type 2 diabetes subtypes have partially distinct genetic backgrounds, suggesting etiological differences that may one day be targeted for treatment. That was the conclusion of genome-wide association analyses. Shailendra Patel, MD, PhD, professor and director of the Division of Endocrinology, Diabetes and Metabolism in the Department of Internal Medicine at the UC College of Medicine provided reaction to the study.
November 18, 2021
COVID-19 cases in the region are rising just ahead of the Thanksgiving holiday. Health experts are concerned about people getting together for the holidays, especially for certain groups. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, was one of the experts interviewed for a story produced by WLWT-TV.
November 10, 2021
UC researchers are taking part in a new nearly $2 million, multiyear study that will help develop a new generation of PPE, or personal protective equipment, for health care workers. UC researchers will work with teams from Iowa State University and the University of California-Davis to improve the design, function and safety of PPE, or personal protective equipment, the university said in a release this week. The study is part of a multi-institutional, four-year grant worth $1.8 million from the Centers for Disease Control and Prevention. The Cincinnati Business Courier published a story on the research.
November 10, 2021
With people wearing masks over the past 18 months or so to ward off COVID-19, the incidence of the common cold has been reduced during that time. However, as more people get vaccines and boosters, and mask mandates are eased in some instances, the common cold could be poised to make a comeback as we head into the fall and winter months. Giddy posted a primer on what causes the common cold and how to combat it and one of the expert sources they cited was Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
November 9, 2021
Spray on skin, called RECELL, is now approved for both adults and children, sparing them the unnecessary pain of dozens of skin grafts. UC Health says it’s the first in the region to use the technology made by Avita. WVXU published a story on the spray, quoting Julia Slater, MD, assistant professor in the Department of Surgery at the UC College of Medicine.
November 9, 2021
The University of Cincinnati and the U.S. Air Force have renewed their cooperative agreement that could mean up to $49 million in research funds. This is the second renewal of the cooperative agreement dating back to 2010.
November 5, 2021
LTC Jeffrey Keenan (Bus ’04) and Stephanie Keenan (CAHS ’04, ’06) are a prominent military couple who have lived in 12 homes during their 15 years of marriage.
November 5, 2021
Verywell Family posted an article featuring experts on whether or not pregnant people should get the COVID-19 booster shot. One of those was Heather Masters, MD, assistant professor in the Department of Obstetrics and Gynecology at the UC College of Medicine.
November 3, 2021
UC is part of a multi-institutional grant of nearly $2 million from the Centers for Disease Control and Prevention to improve the design, function and safety of personal protective equipment. UC researchers will work with teams from Iowa State University and the University of California-Davis on this four-year grant. One of the goals is to develop self-decontaminating PPE featuring high-protection efficiency
November 1, 2021
Christopher Jonathan Slack, MED ’24, knows the meaning of “medically underserved.”
October 29, 2021
The anti-depressant drug fluvoxamine is being looked at by researchers as a possible treatment for COVID-19. A recently released study showed the drug showed a reduced risk of hospitalization and death among COVID patients. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed for a Health.com story on the study results.
October 29, 2021
In a story produced by Spectrum News, Robert Shapiro, MD, professor in the Department of Pediatrics at the UC College of Medicine was quoted on the topic of how helping young people succeed helps build resilient communities.